JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD.;INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES;INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES;中國醫學科學院藥物研究所
发明人:
ZHU, Haibo,SHI, Huijie,SHI, Huijie,史會杰
申请号：
HK18114837
公开号：
HK1255689A1
申请日:
2018.11.20
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention provides an application of triacetyl-3-hydroxyphenyladenosine represented by formula (I) in preventing or treating non-alcoholic fatty liver disease. The triacetyl-3-hydroxyphenyladenosine can significantly reduce the levels of serum AST, ALT and TG, significantly improve liver functions, and alleviate liver steatosis. The invention provides significant curative effects for preventing or treating non-alcoholic fatty liver and has limited toxic side effects.
